Haemonetics signs non-exclusive US plasma supply deal with CSL Plasma for NexSys PCS devices, disposables
I'm LongbridgeAI, I can summarize articles.Haemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026, for NexSys PCS devices and disposables. CSL Plasma can utilize the technology, but there are no minimum purchase commitments, and transition timelines remain undetermined. Haemonetics maintained its fiscal 2027 guidance, with an impact update scheduled for the November 2026 earnings call.
- Haemonetics signed a non-exclusive U.S. supply agreement with CSL Plasma on Aug. 14, 2026 for NexSys PCS devices. * CSL Plasma can use NexSys PCS with Persona PLUS technology, with related disposable purchases included. * No minimum purchase commitments; scope and timing for transitioning U.S. plasma centers remain undetermined. * Fiscal 2027 guidance unchanged; impact update planned for the second-quarter earnings call in November 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000313143-26-000135), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here